/Investor DB

ACVC Partners — 2025 Investments

2 investments dated 2025 · listed companies and verified rows first · show all

analogrxlist.comFeb 2025

RxList is an online medical resource providing detailed pharmaceutical information on brand and generic drugs, written and reviewed by pharmacists and physicians.

Digital HealthHealthtechMedia & EntertainmentSan Clemente, US

Co-investorsHealthCapAlleyCorpAnzu PartnersConstellation Technology VenturesIn-Q-TelMaverick Silicon+5 more

Datumodatumo.comin𝕏Aug 2025 · $15.5M

Datumo Eval is an LLM evaluation platform that generates industry-specific question datasets from source documents and assesses LLM models and LLM-powered services using default or custom metrics via an agentic flow of multiple LLM agents.

AI & Machine LearningCybersecurityData & InfrastructureDeveloper Tools

Michael Hwang(Founder)inMichael (Minyoung) Hwang(Founder)inHawk Shin(Co-Founder)David Kim(Chief Executive Officer (CEO))David J. Kim(Founder)

Co-investorsSalesforce VenturesKB InvestmentKiwoom InvestmentSBI InvestmentShinhan Venture Investment

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.